Physician profile
Benjamin L Dehner
NPI 1649481938
$164,921.78
in general payments reported to CMS, 2019-2025
49 companies · $2,535 in 2025
The $2,535 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,489 · 2020: $317 · 2021: $44K · 2022: $70K · 2023: $43K · 2024: $2,635 · 2025: $2,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Food and Beverage: $6,285 · Consulting Fee: $2,774 · Travel and Lodging: $1,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,945.01 |
| Food and Beverage | $6,285.36 |
| Consulting Fee | $2,773.50 |
| Travel and Lodging | $1,869.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $153,086.24 | 2021-2025 | Urolift, Barrigel |
| Intuitive Surgical, INC. | $2,511.91 | 2019 | |
| Axonics, INC. | $1,928.98 | 2022-2024 | Axonics |
| Pfizer INC. | $881.52 | 2019-2025 | |
| Astellas Pharma US INC | $607.24 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $596.82 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $533.12 | 2019-2025 | Erleada, Akeega, Balversa |
| Endo Pharmaceuticals INC. | $430.96 | 2019-2024 | Xiaflex |
| Boston Scientific Corporation | $426.37 | 2019-2025 | Ams 700 |
| Laborie Medical Technologies Corp. | $286.12 | 2022-2025 | Urgent PC Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter, Eclipse |
| Antares Pharma, INC. | $277.55 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Tolmar, INC. | $248.16 | 2023-2025 | Jatenzo, Eligard |
| Urovant Sciences INC | $227.23 | 2021-2022 | |
| Abbvie INC. | $222.87 | 2023-2025 | Botox |
| Urogen Pharma, INC. | $211.05 | 2021-2025 | Jelmyto |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $206.01 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $180.81 | 2023-2025 | Pylarify |
| Olympus America INC. | $176.13 | 2022-2025 | Itind System |
| Verity Pharmaceuticals INC. | $167.58 | 2023-2025 | Trelstar, Tlando |
| Calyxo, INC. | $163.68 | 2025 | Cvac Aspiration System |
| C. R. Bard, INC. & Subsidiaries | $159.56 | 2024-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Ferring Pharmaceuticals INC. | $149.30 | 2019-2024 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $119.21 | 2019-2024 | |
| Myovant Sciences INC. | $118.83 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $113.76 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Allergan, INC. | $111.62 | 2019-2022 | |
| Coloplast Corp | $61.48 | 2024-2025 | |
| Clarus Therapeutics INC. | $59.17 | 2021 | |
| Uromedica, Incorporated | $51.54 | 2020 | |
| 180 Medical, INC. | $48.86 | 2022-2023 | Gentlecath Glide |
| Stryker Corporation | $48.24 | 2024 | Fluid Management System |
| Ethicon US, LLC | $47.81 | 2024-2025 | Ethicon, Stratafix |
| Dentsply Ih Ab | $44.64 | 2025 | Lofric |
| Medtronic, INC. | $42.05 | 2023-2024 | Interstim |
| Endo USA, INC. | $40.40 | 2025 | Xiaflex |
| Novo Nordisk INC | $38.97 | 2024-2025 | Rivfloza |
| Convatec INC. | $36.71 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $35.50 | 2019 | |
| Photocure INC | $35.00 | 2024 | Cysview |
| Angiodynamics, INC. | $34.40 | 2022-2023 | Nanoknife |
| Kowa Pharmaceuticals America, INC. | $21.74 | 2023 | Seglentis |
| Halozyme INC | $21.62 | 2023 | |
| Sagent Pharmaceuticals | $20.11 | 2024 | Glydo |
| Astrazeneca Pharmaceuticals LP | $19.87 | 2021 | |
| Rochester Medical Corporation | $16.54 | 2019 | |
| Abc Home Medical Supply, INC. | $15.00 | 2024 | |
| Azurity Pharmaceuticals, INC. | $14.36 | 2025 | Azmiro |
| Srs Medical Systems, INC. | $13.34 | 2019 | |
| Palette Life Sciences, INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Dehner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.